NeuroSense Therapeutics NRSN
NASDAQ NRSN
$6.62 +0.27 (+4.25%)
At close: Sep 21, 2026 · 4:00 PM EDT

NeuroSense Therapeutics (NRSN) Net Income towards Common Stockholders (QoQ) (2022 - 2024)

Analysis

NeuroSense Therapeutics (NRSN) Net Income towards Common Stockholders (QoQ) (2022 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Amgen 208.48 Bn 194.49 Bn 7.24 Bn
2 Gilead Sciences 186.29 Bn 183.02 Bn 6.22 Bn
3 Vertex Pharmaceuticals 128.79 Bn 120.93 Bn 2.84 Bn
4 Regeneron Pharmaceuticals 80.66 Bn 72.67 Bn 3.93 Bn
5 Moderna 61.46 Bn 56.32 Bn 52.00 Mn
6 Argenx Se 61.28 Bn 56.10 Bn 1.37 Bn
7 Alnylam Pharmaceuticals 32.04 Bn 28.73 Bn 992.69 Mn
8 Biogen 31.84 Bn 30.56 Bn 1.96 Bn
9 Roivant Sciences 28.74 Bn 29.43 Bn 1.16 Mn
10 NeuroSense Therapeutics 8.09 Mn 7.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 15.95%
Sep 30, 2024 30.46%
Jun 30, 2024 -1.20%
Mar 31, 2024 74.08%
Dec 31, 2023 -876.41%
Sep 30, 2023 184.79%
Jun 30, 2023 32.99%
Mar 31, 2023 -64.61%
Dec 31, 2022 46.50%
Sep 30, 2022 12.81%
Jun 30, 2022 -27.80%
Mar 31, 2022 -154.79%
API Access

NeuroSense Therapeutics Net Income towards Common Stockholders (QoQ) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders-qoq&ticker=NRSN&period=max&api_key=YOUR_API_KEY